Recent Funding
Investors
Janus Henderson Investors

Janus Henderson Investors portfolio

Janus Henderson Investors has 23 portfolio companies on record at Recent Funding, with 11 investments in the last 12 months.

Website: janushenderson.com.

Type: Investor.

Portfolio on Recent Funding: 23.

Deals, last 12 months: 11.

Rounds led: 4 of 23.

Capital in their rounds: $3.19B.

Latest deal: Star Therapeutics · Oct 23, 2026.

About this page

It is an investor based in London, US. It led 4 of the 23 rounds it joined. Its most recent investment on record is Star Therapeutics's $200M Series B+ round in October 2026, which it led, alongside Redmile Group, OrbiMed, Catalio and 6 others. By category, its portfolio leans toward Health and bio (21) and Manufacturing and industrial (2). It has co-invested with RA Capital Management, Logos Capital and Marshall Wace, most often RA Capital Management (11 rounds).

About Janus Henderson Investors

Headquarters: London, US.

Stages: Late Stage.

What Janus Henderson Investors invests in

Janus Henderson Investors recent investments

Company	Round	Date	Alongside
SStar Therapeutics	Series B+ · $200M · lead	Oct 23, 2026	Redmile Group, OrbiMed (lead), Catalio +6
OOMass Therapeutics	Series B+ · $310M	Oct 15, 2026	Jefferson Life Sciences, Novo Holdings (lead), Syncona Partners LLP +6
SSoufflé Therapeutics	Series B+ · $135M	Oct 13, 2026	TAS Partners, Leaps by Bayer, Vida Ventures +6
TTare	Seed · $13M	Sep 16, 2026	Strobe Ventures, Avalanche Foundation, Philip G. Potter +7
EEpicrispr Biotechnologies	Series B+ · $90M · lead	Aug 11, 2026	Duquesne Family Office, Octagon Capital Advisors (lead), Fidelity +5
CClaris Bio	Series B+ · $118M	Jul 28, 2026	Novo Holdings, Adage Capital Management, Mass General Brigham Ventures +5
DDraig Therapeutics	Series B+ · $65M	Jul 14, 2026	Jefferson Life Sciences, Marshall Wace, Deep Track Capital (lead) +1
AAngitia Bio	Series B+ · $130M	Feb 12, 2026	Venrock Healthcare Capital Partners (lead), Wellington Management, Morningside +6

How Janus Henderson Investors invests

Stage	Deals	Capital in rounds
Series B+	17 74%	$2.83B
Series A	5 22%	$347M
Seed	1 4%	$13M

Year	Deals	Capital in rounds
2021	3 13%	$492M
2022	2 9%	undisclosed
2024	6 26%	$452M
2025	2 9%	$485M
2026	10 43%	$1.77B

Janus Henderson Investors portfolio companies

SStar Therapeutics$200MSeries B+ · Oct 2026
OOMass Therapeutics$310MSeries B+ · Oct 2026
SSoufflé Therapeutics$135MSeries B+ · Oct 2026
TTare$13MSeed · Sep 2026
EEpicrispr Biotechnologies$90MSeries B+ · Aug 2026
CClaris Bio$118MSeries B+ · Jul 2026
DDraig Therapeutics$65MSeries B+ · Jul 2026
AAngitia Bio$130MSeries B+ · Feb 2026
CCesiumAstro$470MSeries B+ · Feb 2026
TTenpoint Therapeutics$235MSeries B+ · Jan 2026
AAmbros Therapeutics$125MSeries A · Dec 2025
TTubulis$360MSeries B+ · Oct 2025
335PharmaSeries B+ · Nov 2024
AAlpha-9 Oncology$175MSeries B+ · Oct 2024
TThird Arc Bio$165MSeries A · Jul 2024
AAsher Bio$55MSeries B+ · Apr 2024
CCurevo VaccineSeries A · Nov 2022
EElement Biosciences$276MSeries B+ · Jun 2021
SSynthekine$108MSeries B+ · Jun 2021
NnChroma Biobacker
VVelosbiobacker
WWindward Biobacker
AAmbrosiabiosciencesbacker

Company	Round with Janus Henderson Investors	Total raised	Latest raise
SStar Therapeutics Health and bio	Oct 23, 2026 Series B+ · $200M · lead	$415M	Oct 23, 2026 Series B+
OOMass Therapeutics Health and bio	Oct 15, 2026 Series B+ · $310M	$422.51M	Oct 15, 2026 Series B+
SSoufflé Therapeutics Health and bio	Oct 13, 2026 Series B+ · $135M	$335M	Oct 13, 2026 Series B+
TTare RWA and tokenization	Sep 16, 2026 Seed · $13M	$13M	Sep 16, 2026 Seed
EEpicrispr Biotechnologies Health and bio	Aug 11, 2026 Series B+ · $90M · lead	$158M	Aug 11, 2026 Series B+
CClaris Bio Health and bio	Jul 28, 2026 Series B+ · $118M	$175M	Jul 28, 2026 Series B+
DDraig Therapeutics Health and bio	Jul 14, 2026 Series B+ · $65M	$205M	Jul 14, 2026 Series B+
AAngitia Bio Health and bio	Feb 12, 2026 Series B+ · $130M	$130M	Feb 12, 2026 Series B+
CCesiumAstro Robotics and hardware	Feb 2, 2026 Series B+ · $470M	$1.32B	Nov 8, 2026 Series B+
TTenpoint Therapeutics Health and bio	Jan 29, 2026 Series B+ · $235M · lead	$235M	Jun 12, 2026 Series A
AAmbros Therapeutics Health and bio	Dec 16, 2025 Series A · $125M	$125M	Dec 16, 2025 Series A
TTubulis Health and bio	Oct 16, 2025 Series B+ · $360M	$573M	Oct 16, 2025 Series B+
335Pharma Health and bio	Nov 26, 2024 Series B+	undisclosed	Nov 26, 2024 Series B+
AAlpha-9 Oncology Health and bio	Oct 23, 2024 Series B+ · $175M	$175M	Oct 23, 2024 Series B+
TThird Arc Bio Health and bio	Jul 22, 2024 Series A · $165M	$217M	Feb 4, 2026 Series A
AAsher Bio Health and bio	Apr 16, 2024 Series B+ · $55M	$218M	Apr 16, 2024 Series B+
CCurevo Vaccine Health and bio	Nov 17, 2022 Series A	undisclosed	Mar 18, 2025 Series B+
EElement Biosciences Health and bio	Jun 29, 2021 Series B+ · $276M	$823M	Jun 9, 2026 Series B+
SSynthekine Health and bio	Jun 10, 2021 Series B+ · $108M · lead	$290M	Jan 6, 2023 Series B+
NnChroma Bio Health and bio	backer	$75M	Dec 12, 2024 round
VVelosbio Health and bio	backer	$58M	Aug 2, 2026 Series B+
WWindward Bio Health and bio	backer	$200M	May 5, 2026 round
AAmbrosiabiosciences Health and bio	backer	undisclosed	Mar 31, 2026 Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 23 rounds on Recent Funding that name Janus Henderson Investors. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Janus Henderson Investors, which is a subset of its real portfolio. API: /api/v1/investors/janus-henderson-investors (get a free API key). More: the most active VC firms and new venture capital funds.